PRAE:XETRA:XETRA-Amundi Index Solutions - Amundi Prime Europe UCITS ETF DR (C) (EUR)

ETF | Others |

Last Closing

USD 27.51

Change

0.00 (0.00)%

Market Cap

USD 0.09B

Volume

1.74K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.64 (+1.28%)

USD 509.68B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.20 (+1.26%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.31 (+1.20%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.28 (+1.03%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.18 (+0.77%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.10 (+0.77%)

USD 100.74B
JARI:XETRA Amundi Index Solutions - Amund..

+0.33 (+0.74%)

USD 100.71B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.62 (+1.24%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.82 (-0.15%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.23 (+1.04%)

USD 79.79B

ETFs Containing PRAE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.36% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.36% 69% C- 68% D+
Trailing 12 Months  
Capital Gain 12.70% 66% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.70% 66% D+ 66% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.90% 70% C- 68% D+
Dividend Return 8.90% 69% C- 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.19% 53% F 62% D
Risk Adjusted Return 72.99% 86% B+ 87% B+
Market Capitalization 0.09B 31% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.